Randomized, open-label, comparative study of piperacillin-tazobactam administered by continuous infusion versus intermittent infusion for treatment of hospitalized patients with complicated intra-abdominal infection
about
Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infectionsAntimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials.Clinical outcomes with alternative dosing strategies for piperacillin/tazobactam: a systematic review and meta-analysis.Continuous beta-lactam infusion in critically ill patients: the clinical evidenceContinuous versus intermittent administration of piperacillin-tazobactam in intensive care unit patients with ventilator-associated pneumoniaClinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial.Piperacillin-tazobactam: a beta-lactam/beta-lactamase inhibitor combination.Piperacillin-tazobactam penetration into human pancreatic juice.Pharmacodynamic optimization of beta-lactams in the patient care setting.Resistant pathogen-associated skin and skin-structure infections: antibiotic options.Improved outcomes of patients with end-stage cystic fibrosis requiring invasive mechanical ventilation for acute respiratory failure.The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam (RECEIPT) study: a multicenter study.β-lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: a structured review.Basis for selecting optimum antibiotic regimens for secondary peritonitis.Continuous and Prolonged Intravenous β-Lactam Dosing: Implications for the Clinical Laboratory.Population Pharmacokinetics of Piperacillin in Nonobese, Obese, and Morbidly Obese Critically Ill Patients.Clinical Outcomes of Extended Versus Intermittent Infusion of Piperacillin/Tazobactam in Critically Ill Patients: A Prospective Clinical Trial.Hospital Length of Stay Among Patients Receiving Intermittent Versus Prolonged Piperacillin/Tazobactam Infusion in the Intensive Care Units.Evaluation of an alternative extended-infusion piperacillin-tazobactam dosing strategy for the treatment of gram-negative infections.Gentamicin in bone cement: A potentially more effective prophylactic measure of infectionin joint arthroplastyContinuous infusion of antibiotics in the critically ill: The new holy grail for beta-lactams and vancomycin?Optimal dosing of piperacillin-tazobactam for the treatment of Pseudomonas aeruginosa infections: prolonged or continuous infusion?Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.Continuous versus intermittent infusion of prophylactic cefoxitin after colorectal surgery: a pilot study.Influence of β-Lactam Infusion Strategy on Acute Kidney Injury.
P2860
Q24199096-720407D8-2363-470E-AB57-80C184A410A1Q26739860-B3A0AE73-BF0C-4E70-A412-E8408BC701DAQ33940174-91FC4D9B-36BA-4A7B-8E3A-8463CBC27EE7Q34892334-FFAC18D6-D6B5-4A00-9277-8E761476B7FAQ36329228-54EC4D06-21F0-4072-B3CF-E4BE22396584Q36422575-E532A338-4E64-445F-8B68-31889694D872Q36633761-4E1E3445-E887-47A8-8B60-A6AD074C9B53Q36839703-A5A3BAA0-9D93-452A-9A34-0ED0726FC3EAQ36949427-4DFD5E81-7877-484D-8CAB-1D8BEA5BD59DQ37169843-698A02E2-CF4C-4E35-9AF4-F0717353C7D8Q37785546-EC63E96C-8D58-439E-9F70-50C83B667B70Q37909115-A5FE09C2-4320-4985-B0EC-B512C83B87D9Q37933418-C3861150-43E2-4196-984E-DB905F229724Q38004063-2D3EE47B-B54D-4FCA-8433-6BACA7F96B28Q38633450-530AE500-D537-4CBB-B63D-3051C2DD9546Q38896040-E4A91062-C322-45E9-B414-68B417D981F5Q39040314-F0115923-201F-4BC5-ABB1-7E0D51A8A711Q40078698-1475EB31-8766-4A67-8E6A-88168E22A205Q40219976-3CD360D9-3160-4A4B-9664-771852259371Q40687385-EE8721C9-73F7-4CD8-B7F2-64CE21DDB865Q42266607-B1CEB88E-DBE9-4C8B-9674-F3716A5BA041Q42432137-2CF03DC4-FD85-4F06-B02B-6C2365706E73Q44235811-F683A1C4-28C3-40FE-B7F0-AA29A91CE913Q46034494-CA4C3CA8-A355-4BEA-8C19-1F7E5E67FFEDQ46408015-42B84303-18A1-42D1-8043-A331B681AAE7Q48707595-AA2F5220-9B32-4431-A4CF-71FB8819FE40
P2860
Randomized, open-label, comparative study of piperacillin-tazobactam administered by continuous infusion versus intermittent infusion for treatment of hospitalized patients with complicated intra-abdominal infection
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Randomized, open-label, compar ...... ated intra-abdominal infection
@ast
Randomized, open-label, compar ...... ated intra-abdominal infection
@en
Randomized, open-label, compar ...... ated intra-abdominal infection
@nl
type
label
Randomized, open-label, compar ...... ated intra-abdominal infection
@ast
Randomized, open-label, compar ...... ated intra-abdominal infection
@en
Randomized, open-label, compar ...... ated intra-abdominal infection
@nl
prefLabel
Randomized, open-label, compar ...... ated intra-abdominal infection
@ast
Randomized, open-label, compar ...... ated intra-abdominal infection
@en
Randomized, open-label, compar ...... ated intra-abdominal infection
@nl
P2093
P2860
P3181
P356
P1476
Randomized, open-label, compar ...... ated intra-abdominal infection
@en
P2093
Adrian Dana
David Mercer
David P Nicolau
Debra Mansfield
Joseph L Kuti
Kamal M Itani
William K Lau
P2860
P304
P3181
P356
10.1128/AAC.00329-06
P407
P577
2006-11-01T00:00:00Z